3. Sakai K, Sakuma K. Sarcopenic dysphagia as a new concept. In: Dionyssiotis Y, editors. Sarcopenic dysphagia as a new concept. Rijeka, Croatia: IntechOpen; 2017.
5. Altman KW, Yu GP, Schaefer SD. Consequence of dysphagia in the hospitalized patient: impact on prognosis and hospital resources. Arch Otolaryngol Head Neck Surg 2010;136:784–9.
8. Rochon PA, Petrovic M, Cherubini A, Onder G, O’Mahony D, Sternberg SA, et al. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev 2021;2:e290–300.
10. Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc 2020;21:181–7.
17. Ganz DA, Latham NK. Prevention of falls in community-dwelling older adults. N Engl J Med 2020;382:734–43.
21. By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023;71:2052–81.
31. Kunieda K, Ohno T, Fujishima I, Hojo K, Morita T. Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale. J Pain Symptom Manage 2013;46:201–6.
32. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676–82.
33. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020;21:300–7.
37. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol 2009;60:549–76.
39. Cantoni E, Ronchetti E. Robust inference for generalized linear models. J Am Stat Assoc 2001;96:1022–30.
43. R Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation; 2019 [cited 2024 Feb 25]. Available from:
https://www.R-project.org/.
44. Toh JJY, Zhang H, Soh YY, Zhang Z, Wu XV. Prevalence and health outcomes of polypharmacy and hyperpolypharmacy in older adults with frailty: a systematic review and meta-analysis. Ageing Res Rev 2023;83:101811.
46. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA; OLDY (OLd people Drugs & dYsregulations) Study Group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008;65:130–3.